JP Morgan Chase’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-318,800
Closed -$11.7M 6312
2021
Q1
$11.7M Buy
+318,800
New +$11.3M ﹤0.01% 2216

Other funds holding AHCO

JP Morgan Chase's AHCO Position: Q2 2026 in Review

JP Morgan Chase reduced its AdaptHealth (AHCO) stake by 25% in Q2 2026, selling an estimated $486K and leaving 131,152 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #4456.

JP Morgan Chase first reported a position in AHCO in Q2 2020 and has held it in 25 quarters since. The position peaked at $35.1M in Q1 2021. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • JP Morgan Chase held 131,152 shares of AdaptHealth worth $1.38M as of Q2 2026.
  • JP Morgan Chase sold 43,573 AdaptHealth shares in Q2 2026, an estimated $486K.
  • AdaptHealth made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4456 holding.
  • JP Morgan Chase first reported a position in AdaptHealth in Q2 2020 and has held it in 25 quarters since.
  • JP Morgan Chase's AdaptHealth position peaked at $35.1M in Q1 2021.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.